| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.008 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.008 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.009 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.009 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |